HM

Himanshu Mishra

Active Director Director DIN 10116449
DIN 10116449 First appointment Apr 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Himanshu Mishra

Data last updated:

Himanshu Mishra is a Director at Velesila Pharmaceuticals Private Limited (since 2023). The company operates in Paper. Velesila Pharmaceuticals Private Limited reported revenue of ₹26.1 Lakh (FY 2025).

DIN 10116449
Primary Designation Director
Industry Paper
First Appointment 17 Apr 2023
Oldest Company Age 3 yrs
Largest company Velesila Pharmaceuticals Private Limited · ₹26.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Apr 20232023₹26.1 Lakh (FY 2025)Active

Board colleagues of Himanshu Mishra

Directorship timeline

Open interactive timeline →
Velesila Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Himanshu Mishra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Himanshu Mishra

Himanshu Mishra currently holds 1 directorship: Velesila Pharmaceuticals Private Limited (Director, since 17 Apr 2023, revenue ₹26.1 Lakh (FY 2025)).

Himanshu Mishra was first appointed on 17 Apr 2023 as Director at Velesila Pharmaceuticals Private Limited.

The current boards of Himanshu Mishra's companies include Sudhir Kumar Bhatta (Velesila Pharmaceuticals Private Limited), Sunil Kumar Mishra (Velesila Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available